Early research (Phase 1)Ended earlyNCT03971734
What this trial is testing
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
Who this might be right for
High Grade GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7